Medikaloka Hermina PT (HEAL) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.032x

Based on the latest financial reports, Medikaloka Hermina PT (HEAL) has a cash flow conversion efficiency ratio of 0.032x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp225.37 Billion ≈ $13.21 Million USD) by net assets (Rp7.01 Trillion ≈ $410.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Medikaloka Hermina PT - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Medikaloka Hermina PT's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Medikaloka Hermina PT balance sheet liabilities for a breakdown of total debt and financial obligations.

Medikaloka Hermina PT Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medikaloka Hermina PT ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Turk Tuborg Bira ve Malt Sanayi AS
IS:TBORG
0.034x
Dazhong Transportation Group Co Ltd A
SHG:600611
0.028x
Xeris Pharmaceuticals Inc
NASDAQ:XERS
1.464x
Zhejiang Taitan Co Ltd
SHE:003036
0.018x
Helia Group Ltd
AU:HLI
0.027x
Paradise Co. Ltd
KQ:034230
0.028x
Zhongtong Bus Holding Co Ltd
SHE:000957
0.118x
Sinar Mas Agro Resources and Technology Tbk PT
JK:SMAR
0.103x

Annual Cash Flow Conversion Efficiency for Medikaloka Hermina PT (2015–2024)

The table below shows the annual cash flow conversion efficiency of Medikaloka Hermina PT from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see Medikaloka Hermina PT (HEAL) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Rp5.87 Trillion
≈ $343.74 Million
Rp1.14 Trillion
≈ $66.66 Million
0.194x -23.61%
2023-12-31 Rp5.20 Trillion
≈ $304.60 Million
Rp1.32 Trillion
≈ $77.33 Million
0.254x +136.20%
2022-12-31 Rp4.69 Trillion
≈ $274.55 Million
Rp503.58 Billion
≈ $29.51 Million
0.107x -74.60%
2021-12-31 Rp4.39 Trillion
≈ $257.02 Million
Rp1.86 Trillion
≈ $108.77 Million
0.423x +27.07%
2020-12-31 Rp3.38 Trillion
≈ $198.18 Million
Rp1.13 Trillion
≈ $66.01 Million
0.333x +60.80%
2019-12-31 Rp2.76 Trillion
≈ $161.98 Million
Rp572.58 Billion
≈ $33.55 Million
0.207x +103.10%
2018-12-31 Rp2.37 Trillion
≈ $138.86 Million
Rp241.67 Billion
≈ $14.16 Million
0.102x -79.03%
2017-12-31 Rp956.53 Billion
≈ $56.05 Million
Rp465.08 Billion
≈ $27.25 Million
0.486x +68.84%
2016-12-31 Rp1.26 Trillion
≈ $73.83 Million
Rp362.85 Billion
≈ $21.26 Million
0.288x +7.84%
2015-12-31 Rp957.59 Billion
≈ $56.11 Million
Rp255.71 Billion
≈ $14.98 Million
0.267x --

About Medikaloka Hermina PT

JK:HEAL Indonesia Medical Care Facilities
Market Cap
$1.04 Billion
Rp17.67 Trillion IDR
Market Cap Rank
#8948 Global
#91 in Indonesia
Share Price
Rp1150.00
Change (1 day)
-1.71%
52-Week Range
Rp1150.00 - Rp1760.00
All Time High
Rp971874.91
About

PT Medikaloka Hermina Tbk, together with its subsidiaries, operates a network of hospitals in Indonesia. The company offers services in the areas of medical acupuncture, pediatrics, surgery, orthopedic surgery, plastic and reconstructive surgery, emergency medicine, forensic and medicolegal, dentistry, clinical nutrition, integrative medicine, cardiology, obstetrics and gynecology, nuclear medici… Read more